The optimal time for the initiation of in vitro fertilization and embryo transfer among women with atypical endometrial hyperplasia and endometrial carcinoma receiving fertility-sparing treatment.

Ziyi SongHuixin LiuRong ZhouZerui XiaoJianliu WangHaibo WangQun Lu

Published in: Archives of gynecology and obstetrics (2021)

Initiating IVF-ET 3 months after ceasing high-dose progesterone therapy can lead to better outcomes of controlled ovarian hyperstimulation for women with endometrial cancer or atypical endometrial hyperplasia.

Keyphrases

endometrial cancer
high dose
low dose
stem cell transplantation
robot assisted
type diabetes
estrogen receptor
insulin resistance
weight loss